-
-
-
Several years ago, the PROWESS trial demonstrated a mortality benefit for drotrecogin alfa [activated] (DrotAA; APC) in patients with severe sepsis, and that this benefit was most pronounced in those at high risk of death (ie, APACHE score > 25 or multi-organ dysfunction).
-
The sample for this study comprised 15,846 patients admitted to 51 adult ICUs in 31 hospitals participating in the Centers for Disease Control and Prevention's Nosocomial Infection Surveillance system.
-
The population of the United States is aging and by 2020, there will be 51 million Americans over the age of 65 years.
-
High-Dose Statin Therapy, Value for Older Adults; Simvastatin, Best for
Parkinson's Disease; Polyethylene Glycol for Chronic Constipation; FDA
Actions
-
-
Older women taking SSRIs had higher rates of hip bone loss compared to both nonusers and TCA users, when measured twice over an average of 5 years.
-
Although anti-reflux surgery seems to be declining in the United States, there are still many such operations undertaken. However, new data make it clear that very few patients are candidates for fundoplication.
-
After a positive coronary CT scan, patients often undergo stress myocardial perfusion scanning, but the relationship between these two tests in relation to prognosis is poorly understood.
